Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, TR Pacheco, A Costa… - OncoTargets and …, 2012 - Taylor & Francis
Introduction: Somatostatin analogs (SSAs) are used as part of standard treatment for
advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative …
被引用次数：17 相关文章

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, TR Pacheco, A Costa… - OncoTargets and …, 2012 - search.proquest.com
Abstract Introduction: Somatostatin analogs (SSAs) are used as part of standard treatment
for advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative …
[HTML] nih.gov

[HTML][HTML] Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, TR Pacheco, A Costa… - OncoTargets and …, 2012 - ncbi.nlm.nih.gov
Results: A positive association between p-AKT and p-S6 expression was identified (P= 0.01)
and higher expression of both markers was observed in pancreatic NETs. AKT/mTOR …
[PDF] psu.edu

[PDF][PDF] Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes - OncoTargets and Therapy, 2012 - Citeseer
Patients and methods: Expression of phosphatase and tensin homolog (PTEN),
phosphorylated (p)-AKT (Ser473), and p-S6 (Ser240/244) was evaluated using …

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, T Pacheco, A Costa, AC Santos… - OncoTargets and …, 2012 - repositorio.ul.pt
Introduction: Somatostatin analogs (SSAs) are used as part of standard treatment for
advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative …

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, TR Pacheco, A Costa… - OncoTargets and …, 2012 - dovepress.com
Results: A positive association between p-AKT and p-S6 expression was identified (P= 0.01)
and higher expression of both markers was observed in pancreatic NETs. AKT/mTOR …

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs.

I Fernandes, TR Pacheco, A Costa… - OncoTargets & …, 2012 - search.ebscohost.com
Abstract Introduction: Somatostatin analogs (SSAs) are used as part of standard treatment
for advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative …
[PDF] scienceopen.com

[PDF][PDF] Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes - OncoTargets and Therapy, 2012 - scienceopen.com
Patients and methods: Expression of phosphatase and tensin homolog (PTEN),
phosphorylated (p)-AKT (Ser473), and p-S6 (Ser240/244) was evaluated using …

Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes, TR Pacheco, A Costa, AC Santos… - OncoTargets and …, 2012 - go.gale.com
Introduction: Somatostatin analogs (SSAs) are used as part of standard treatment for
advanced neuroendocrine tumors (NETs). The mechanisms behind the antiproliferative …
[PDF] unl.pt

[PDF][PDF] Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs

I Fernandes - OncoTargets and Therapy, 2012 - research.unl.pt
Patients and methods: Expression of phosphatase and tensin homolog (PTEN),
phosphorylated (p)-AKT (Ser473), and p-S6 (Ser240/244) was evaluated using …